Results 61 to 70 of about 168,097 (250)

Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial

Cardiovascular Diabetology
Background Clinical trials have established the prognostic benefits of sodium‒glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) and heart failure (HF) with preserved ejection fraction (HFpEF), although the ...
Artem Ovchinnikov, Alexandra Potekhina, Anastasiia Filatova, Olga Svirida, Kristina Zherebchikova, Fail Ageev, Evgeny Belyavskiy   +6 more
doaj   +1 more source

Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundClinical benefits from His bundle pacing (HBP) in heart failure patients with preserved and reduced left ventricular ejection fraction are still inconclusive.
Weijian Huang, Lan Su, Shengjie Wu, Lei Xu, Fangyi Xiao, Xiaohong Zhou, Kenneth A. Ellenbogen   +6 more
doaj   +1 more source

Sacubitril and valsartan fixed combination to reduce heart failure events in post-acute myocardial infarction patients [PDF]

, 2017
Heart failure is a term used to define a constellation of symptoms and signs that are commonly attributed to the inability of the heart to produce a cardiac output that meets the demands of the body. It remains a deadly disease, affecting between 1-2% of
Lang, C. C., Zaid Iskandar, M.
core   +2 more sources

Heart Failure With Preserved Ejection Fraction and Obesity

JACC: Case Reports, 2020
This report describes a case of heart failure with preserved ejection fraction in a post-menopausal woman with obesity. The case highlights a metabolic phenotype of heart failure with preserved ejection fraction that commonly manifests in women, with the
Arjun Sinha, MD, Clyde W. Yancy, MD, Sanjiv J. Shah, MD, Sadiya S. Khan, MD   +3 more
doaj   +1 more source

NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction

Circulation Research, 2021
Supplemental Digital Content is available in the text. Rationale: Heart failure with preserved ejection fraction (HFpEF) is a mortal clinical syndrome without effective therapies.
Dan Tong, G. Schiattarella, Nan Jiang, Francisco Altamirano, P. Szweda, Abdallah Elnwasany, Dong I. Lee, Heesoo Yoo, D. Kass, L. Szweda, S. Lavandero, E. Verdin, T. Gillette, Joseph A. Hill   +13 more
semanticscholar   +1 more source

Genetic Risk and Atrial Fibrillation in Patients with Heart Failure [PDF]

, 2020
Aims: To study the association between an atrial fibrillation (AF) genetic risk score with prevalent AF and all-cause mortality in patients with heart failure.
Anker, Stefan D., Artola, Vicente A., Benjamin, Emelia J., Dickstein, Kenneth, Filippatos, Gerasimos S., Kloosterman, Mariëlle, Koekemoer, Andrea, Lam, Carolyn S. P., Lang, Chim, Meer, Peter van der, Metra, Marco, Nelson, Christopher P., Ng, Leong L., Ponikowski, Piotr, Rienstra, Michiel, Romaine, Simon P. R., Roselli, Carolina, Samani, Nilesh J., Santema, Bernadet T., van der Harst, Pim, Van Gelder, Isabelle C., Van Veldhuisen, Dirk Jan, Voors, Adriaan A.   +22 more
core   +3 more sources

A case report of a patient with heart failure with preserved ejection fraction presented as dysphagia

ESC Heart Failure, 2023
Dysphagia is a common clinical symptom in older people that can be attributed to a wide range of diseases, extending from neoplasm to gastroesophageal reflux diseases such as stroke or achalasia.
Elena Leonidou, Maria Ioannou, Petros Mavrommatis, Angeliki Mouzarou   +3 more
doaj   +1 more source

Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction.

Diabetes Care, 2022
OBJECTIVE To assess whether the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin improves cognitive impairment in frail older adults with diabetes and heart failure with preserved ejection fraction (HFpEF).
P. Mone, A. Lombardi, J. Gambardella, A. Pansini, Gaetano Macina, M. Morgante, Salvatore Frullone, G. Santulli   +7 more
semanticscholar   +1 more source

The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study [PDF]

, 2014
Background Nationally, symptomatic heart failure affects 1.5-2% of Canadians, incurs $3 billion in hospital costs annually and the global burden is expected to double in the next 1–2 decades.
Anderson, Todd J., Becher, Harald, Belenkie, Israel, Clark, Alexander M., Duff, Henry J., Dyck, Jason R. B., Ezekowitz, Justin A., Fredrich, Matthias G., Haykowsky, Mark J., Howlett, Jonathan G., Kassiri, Zamaneh, Kaul, Padma, Kim, Daniel H., Knudtson, Merril L., Light, Peter E., Lopaschuk, Gary D., McAlister, Finlay A., Noga, Michelle L., Oudit, Gavin Y., Paterson, D. Ian, Quan, Hude, Schulz, Richard, Thompson, Richard B., Weeks, Sarah G.   +23 more
core   +1 more source

Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea.

JAMA cardiology, 2022
Importance Diagnosis of heart failure with preserved ejection fraction (HFpEF) among dyspneic patients without overt congestion is challenging. Multiple diagnostic approaches have been proposed but are not well validated against the independent gold ...
Y. Reddy, D. Kaye, M. L. Handoko, A. A. van de Bovenkamp, R. Tedford, Carson Keck, M. Andersen, K. Sharma, R. Trivedi, R. Carter, M. Obokata, F. Verbrugge, M. Redfield, B. Borlaug   +13 more
semanticscholar   +1 more source